Evaluation of controller medication efficiency in patients with moderate and severe uncontrolled asthma

QR Code (код быстрого отклика)

Evaluation of controller medication efficiency in patients with moderate and severe uncontrolled asthma

Evaluation of efficiency of controller medication (combination of fluticasone propionate and Salmeterol) in 40 patients (age from 18 to 65 years) with moderate (n = 15) and severe (phenotype brittle n = 10, asthma with fixed obstruction n = 15) uncontrolled asthma was evaluated in open prospective t...

Полное описание

Сохранить в:

Библиографические подробности
Главный автор:	P. A. Selivanova
Формат:	Статья
Язык:	английский
Опубликовано:	Siberian State Medical University (Tomsk) 2009-02-01
Серии:	Бюллетень сибирской медицины
Предметы:	bronchial asthma severe asthma combined therapy
Online-ссылка:	https://bulletin.ssmu.ru/jour/article/view/1747
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Dynamics of gas evolutions in patients with a heavy bronchial asthma on a background of basic anti-inflammatory therapy
по: L. A. Krasnobayeva, и др.
Опубликовано: (2010-12-01)

GENE EXPRESSION DYNAMICS IN PATIENTS WITH SEVERE THERAPY-RESISTANT ASTHMA DURING TREATMENT PERIOD
по: Ye. S. Kulikov, и др.
Опубликовано: (2014-02-01)

Evaluation of serum Vitamin D3 level and its association with the severity of asthma and asthma control among the adult Indian population with bronchial asthma: A cross-sectional study
по: Dhwani Patel, и др.
Опубликовано: (2025-01-01)

Using the method of laser spectroscopy in the evaluation of the therapy effectiveness in patients with severe bronchial asthma
по: L. A. Krasnobayeva, и др.
Опубликовано: (2011-08-01)

Modern Understanding of Severe Bronchial Asthma
по: A. Yu. Kraposhina, и др.
Опубликовано: (2022-03-01)

IMMUNOLOGICAL MARKERS OF UNCONTROLLED ATOPIC BRONCHIAL ASTHMA IN CHILDREN
по: M. V. Smolnikova, и др.
Опубликовано: (2017-08-01)

Socio-psychological problems in adolescents with uncontrolled bronchial asthma
по: L. S. Evert, и др.
Опубликовано: (2025-01-01)

Quality of life in patients having severe bronchial asthma
по: T. V. Smetanenko, и др.
Опубликовано: (2005-12-01)

Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma
по: Mobayed H, и др.
Опубликовано: (2025-05-01)

Achievement of Control of Severe Bronchial Asthma When Using Dupilumab
по: O. V. Kazmerchuk, и др.
Опубликовано: (2024-11-01)

COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
по: V. A. Nikitin, и др.
Опубликовано: (2016-03-01)

Is Biologic Therapy an Effective Tool for Achieving Remission in Severe Asthma? A Retrospective Study in Central Romania
по: Corina Mărginean, и др.
Опубликовано: (2025-07-01)

Efficiency of tiotropium bromide in patients with severe persistent bronchial asthma in clinical practice
по: A. F. Ivanov, и др.
Опубликовано: (2018-04-01)

PRIMARY RESULTS OF LONG-TERM DYNAMIC MONITORING OF CHILDREN WITH BRONCHIAL ASTHMA OF UNCONTROLLED SEVERE PERSISTENT COURSE
по: L. S. Namazova-Baranova, и др.
Опубликовано: (2017-02-01)

SOME FUNCTIONAL FEATURES OF COURSE OF BRONCHIAL ASTHMA COMBINED WITH ESSENTIAL HYPERTENSION
по: O. M. Uryasev, и др.
Опубликовано: (2015-09-01)

ANALYSIS OF THE ASSOCIATION OF POLYMORPHIC LOCUS RS1138272 OF GSTР1 GENE WITH BRONCHIAL ASTHMA AND PECULIARITIES OF ITS COURSE
по: G. F. MUKHAMMADIYEVA, и др.
Опубликовано: (2017-09-01)

CYTOKINE GENES AS GENETIC MARKERS OF CONTROLLED AND UNCONTROLLED ATOPIC BRONCHIAL ASTHMA
по: M. V. Smolnikova, и др.
Опубликовано: (2017-10-01)

CLINICAL-IMMUNOLOGICAL EFFECTIVENESS OF RIBOMUNYL IN CHILDREN WITH VIRUS-INDUCED BRONCHIAL ASTHMA
по: E. B. Belan, и др.
Опубликовано: (2020-12-01)

Clinic and treatment of bronchial asthma, combined with cardiovascularpathology
по: N. V. Gordeyeva, и др.
Опубликовано: (2007-06-01)

Genetically Engineered Biologic Drugs in Management of Children with Bronchial Asthma
по: Svetlana V. Zaytseva, и др.
Опубликовано: (2021-12-01)

The effectiveness of medical care to patients with asthma in Tomsk Region
по: O. S. Kobyakova, и др.
Опубликовано: (2011-02-01)

PATHOGENETIC JUSTIFICATION AND EFFICIENCY OF MELATONIN APPLICATION IN PATIENTS WITH BRONCHIAL ASTHMA
по: G. I. Litvinenko, и др.
Опубликовано: (2014-07-01)

SYSTEMIC ENZYME THERAPY IN COMPLEX TREATMENT OF PATIENTS WITH SEVERE BRONCHIAL ASTHMA
по: E. V. Churyukina, и др.
Опубликовано: (2019-05-01)

Targeted therapy of bronchial asthma in children
по: R. M. Fayzullina, и др.
Опубликовано: (2022-07-01)

Efficacy of Benralizumab in Reducing FeNO in Severe Eosinophilic Asthma: The Role of CRSwNP
по: Garcia-Rivero JL, и др.
Опубликовано: (2025-05-01)

Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region
по: A. D. Ermolaeva, и др.
Опубликовано: (2021-07-01)

EVALUATION OF HYGIENE KNOWLEDGE OF CHILDREN WITH ASTHMA
по: S.Ye. Leschuk
Опубликовано: (2018-03-01)

The role of extrapulmonary personalized factors in asthma control
по: L. V. Tribuntceva, и др.
Опубликовано: (2023-03-01)

Epidemiological trends of bronchial asthma symptoms in adolescent children in the Udmurt Republic. The results of long-term research
по: L. P. Matveeva, и др.
Опубликовано: (2025-06-01)

The Long-Term Omalizumab Therapy in Children with Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry
по: Elena A. Vishneva, и др.
Опубликовано: (2018-05-01)

FEATURES OF TRANSFORMATIONS OF RED BLOOD CELLS IN CHILDREN WITH BRONCHIAL ASTHMA
по: E. N. Suprun, и др.
Опубликовано: (2017-12-01)

CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA
по: Elena Albertovna Sobko, и др.
Опубликовано: (2015-09-01)

SOME FEATURES OF CHANGING TELOMERE LENGTH IN LYMPHOCYTES FROM THE PATIENTS WITH BRONCHIAL ASTHMA
по: V. I. Borisov, и др.
Опубликовано: (2014-07-01)

Phenotypic features of a patient with bronchial asthma in the clinical practice of a pediatrician
по: R. N. Khokha, и др.
Опубликовано: (2023-07-01)

ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES
по: V. S. Krysanova, и др.
Опубликовано: (2021-08-01)

Model for predicting the risk of severe bronchial asthma in children
по: O. E. Semernik, и др.
Опубликовано: (2023-08-01)

Periostin as a predictor of uncontrolled asthma and lung function decrease in patient of different age groups
по: A. V. Kamaev
Опубликовано: (2021-06-01)

Problem of comorbidity in patients with bronchial asthma
по: D. V. Ushakova, и др.
Опубликовано: (2021-06-01)

Airway hyperresponsiveness in bronchial asthma: pathogenesis basics
по: I. A. Deyev, и др.
Опубликовано: (2002-12-01)

THE SPECIFIC FEATURES OF CLINICAL AND LABORATORY DIAGNOSTICS OF ASTHMA AND PAECILOMYCES INFECTIONS AND THE PERSPECTIVES OF ETIOTROPIC THERAPY
по: V. M. Akhunov
Опубликовано: (2013-09-01)